The major adverse reactions of CDK4/6 inhibitors are leukopenia and neutropenia, mainly caused by palbociclib and ribociclib, and for this reason, they are dosed with three weeks of treatment and one week of treatment discontinuation to recover neutrophil counts [46]. Here, CDK4 is linked to neutropenia.